Compare J B Hunt Transport Services Inc (JBHT) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J B Hunt Transport Services Inc vs Natera Inc. Common Stock — how do they compare? J B Hunt Transport Services Inc trades at $230.52 (market cap $21.52B), while Natera Inc. Common Stock trades at $394.6 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 2.7× J B Hunt Transport Services Inc's market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold J B Hunt Transport Services Inc for 46 Days and Natera Inc. Common Stock for 0 Days on average.
| JBHT | NTRA | |
|---|---|---|
Market Cap | $21.52B | $57.03B |
Volume | 994,790 | 1,131,157 |
Sector | Industrials | Health |
52-Week High | $298.41 | $425.64 |
52-Week Low | $138.83 | $179.42 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | $22.66B | $56.18B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBHT trades at $232.16, up 1.69% today, with a bearish technical signal but strong fundamental profitability. Recent earnings have consistently beaten expectations, with Q3 2026 results due October 15, 2026. The company maintains solid margins, with a net income margin of 5.31% and ROE of 18.45%, though revenue has declined from 2022 peaks. Cash flow from operations remains healthy at $1.68 billion for 2025.
Analyst consensus is bullish with a $287.93 price target, but near-term risks include rising costs pressuring Q3 earnings and multiple law firm investigations into potential securities claims. The stock offers upside if execution improves, but investors face headwinds from fuel expenses and legal overhangs.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
